Subscribe

News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Subscribe

Charlotte Jones-Burton MD, MS

Otsuka Pharmaceuticals Development and Commercialization

Articles by Charlotte Jones-Burton MD, MS

Is Model Informed Drug Development Regulatory Pathway an Exception or the Norm?

ByCharlotte Jones-Burton MD, MS

September 27th 2021

MIDD can pave new road for drug development.

Latest Updated Articles

Trending on PharmExec

JP Morgan 2026: Regeneron Focusing on Broad Pipeline Development

JP Morgan 2026: Merck’s De-risking of Future Funding

JP Morgan 2026: Bayer’s Rejuvenated Portfolio

JP Morgan 2026: Moderna Planning Seasonal Respiratory Vaccine Franchise

What Defined 2025 for Re-Vana?